Literature DB >> 1163479

Vitamin B6 deficiency in uremia.

W J Stone, L G Warnock, C Wagner.   

Abstract

Significant decreases in plasma pyridoxal-5-phosphate (PLP), plasma glutamic-oxaloacetic transaminase (PGOT) and erythrocyte glutamic-oxaloacetic transaminase (EGOT) were found in 29 uremic patients including 14 who had been on hemodialysis an average of 15.8 months. The mean PLP values of the uremic patients (5.39 +/- 0.37 ng/ml) were clearly lower than the values obtained for the normal group (9.30 +/- 0.80 mg/ml). The mean PGOT values of the uremic patients (dialyzed 4.07 +/- 0.29 U/liter, undialyzed 5.31 +/- 0.49 U/liter) were significantly lower than the normal group (6.57 +/- 0.39 U/liter). The mean EGOT value of the uremic patients (325 +/- 17 U/liter) was also lower than normal subjects (416 +/-21 U/liter). Stimulation of the EGOT by exogenous PLP (EGOT index) was less in dialyzed patients (1.60) than normal subjects (1.80) while the undialyzed uremic subjects had a greater than normal stimulation (2.12). All of these results indicate that uremic patients are vitamin B6 deficient and that those undergoing hemodialysis may have decreased amounts of the EGOT apoenzyme.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1163479     DOI: 10.1093/ajcn/28.9.950

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  5 in total

1.  Vitamin B6 status in uremia.

Authors:  F J Laso Guzmán; J M González-Buitrago; R Vela; F Cava; S de Castro
Journal:  Klin Wochenschr       Date:  1990-02-01

2.  [Intra-erythrocytic GOT activity in uremia and its behavior following pyridoxine administration].

Authors:  P Balcke; P Schmidt; J Zazgornik; H Kopsa
Journal:  Klin Wochenschr       Date:  1983-09-01

3.  Intestinal hydrolysis of pyridoxal 5'-phosphate in vitro and in vivo in the rat. Effect of amino acids and oligopeptides.

Authors:  H M Middleton
Journal:  Dig Dis Sci       Date:  1990-01       Impact factor: 3.199

4.  Association of aspartate aminotransferase with mortality in hemodialysis patients.

Authors:  Vanessa Ravel; Elani Streja; Miklos Z Molnar; Sepideh Rezakhani; Melissa Soohoo; Csaba P Kovesdy; Kamyar Kalantar-Zadeh; Hamid Moradi
Journal:  Nephrol Dial Transplant       Date:  2015-09-01       Impact factor: 5.992

5.  Excessive myocardial calcinosis in a chronic hemodialyzed patient.

Authors:  J Zazgornik; P Balcke; A Rokitansky; P Schmidt; H Kopsa; E Minar; W Graninger
Journal:  Klin Wochenschr       Date:  1987-01-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.